Identifying critical state of complex diseases by single-sample Kullback-Leibler divergence.
Zhong J, Liu R, Chen P. · 2020
Read Identifying critical state of complex diseases by single-sample Kullback-Leibler divergence. by Zhong J, Liu R, Chen P. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6988219.txt.
Introduction
Zhong and co-authors present a method that spots the warning point before a complex disease tips into crisis. Their study appeared in BMC Genomics. Many diseases pass through a fragile pre-disease state before sudden worsening. Clinics usually have a single sample per patient, which defeats most statistics.
Their index, called single-sample Kullback-Leibler divergence, measures how far one case sample disturbs a healthy reference background. A sharp jump in that measure flags the critical state. The method was tested on simulations and on six real data sets. These included several cancers and acute lung injury. In each, it found the pre-disease stage and marker genes that signal it. The authors aim at personal early warning, where treatment might still head off the crash.
Catalog record
| CREATOR | Zhong J, Liu R, Chen P. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Identifying critical state of complex diseases by single-sample Kullback–Leibler divergence By Jiayuan Zhong, Rui Liu, Pei Chen Published in: BMC Genomics DOI: 10.1186/s12864-020-6490-7 ABSTRACT Abstract Background Developing effective strategies for signaling the pre-disease state of complex diseases, a state with high susceptibility before the disease onset or deterioration, is urgently needed because such state usually followed by a catastrophic transition into a worse stage of disease. However, it is a challenging task to identify such pre-disease state or tipping point in clinics, where only one single sample is available and thus results in the failure of most statistic approaches. Methods In this study, we presented a single-sample-based computational method to detect the early-warning signal of critical transition during the progression of complex diseases. Specifically, given a set of reference samples which were regarded as background, a novel index called single-sample Kullback–Leibler divergence (sKLD), was proposed to explore and quantify the disturbance on the background caused by a case sample. The pre-disease state is then signaled by the significant change of sKLD. Results The novel algorithm was developed and applied to both numerical simulation and real datasets, including lung squamous cell carcinoma, lung adenocarcinoma, stomach adenocarcinoma, thyroid carcinoma, colon adenocarcinoma, and acute lung injury. The successful identification of pre-disease states and the corresponding dynamical network biomarkers for all six datasets validated the effectiveness and accuracy of our method. Conclusions The proposed method effectively explores and quantifies the disturbance on the background caused by a case sample, and thus characterizes the criticality of a biological system. Our method not only identifies the critical state or tipping point at a single sample level, but also provides the sKLD-signaling markers for further practical application. It is therefore of great potential in personalized pre-disease diagnosis. Keywords: Tipping point, Dynamic network biomarker (DNB), Pre-disease state, Critical transition, Single-sample Kullback–Leibler divergence (sKLD) BACKGROUND Critical transitions are sudden and large-scale state transitions that occur in many complex systems, such as ecological systems [1, 2], climate systems [3, 4], financial markets [5, 6], microorganism populations [7], psychiatric conditions [8],infectious disease spreading [9] and the human body [10]. Recently, considerable evidence suggests that during the progression of many complex diseases, e.g. cancer [11], asthma attacks [12], epileptic seizures [13] the deterioration is not always smooth but abrupt, inferring the existence of a so-called tipping point, at which a drastic or qualitative transition may occur. Accordingly, the progression of a complex disease can be roughly divided into three stages regardless of specific biological and pathological differences during the progression of diseases, that is, (1) a normal state, a steady state representing the relatively healthy stage and with high resilience; (2) a pre-disease state, which is the limit of the normal state immediately before the onset of deterioration, and with low resilience and high susceptibility; and (3) a disease state, the other steady state with high resilience after the qualitative deterioration (Fig. 1a). It is important to predict the tipping point, so as to prevent or at least get ready for the upcoming deterioration by taking appropriate intervention actions. Recently, we proposed a theoretic framework, called the dynamical network biomarker (DNB) concept [10, 14] for identifying the pre-disease state of complex diseases. This DNB concept, directly from the critical slowing-down theory [15, 16], provides statistical method to select relevant variables for the pre-disease state, that is, a small group of closely related variables (DNBs) convey early warning signals for the impending critical transition by some drastic statistical indices [17, 18]. The DNB theory and its extensions have been applied to several cases, detected the tipping points of endocrine resistance [19] as well as cellular differentiation [20], investigated the immune checkpoint blockade [21], and helped to find the corresponding pre-disease states of several diseases [18, 22–26]. However, DNB method requires multiple samples at each time point, which are generally not available in clinics and other practical cases, thus significantly restricting the application of DNB method in most real cases. Therefore, when there is only a single case sample available, it requires new computational method to explore the critical information, detect the early-warning signal and identify the pre-disease state. [Figure: The outline for detecting the early-warning signal of a pre-disease state based on sKLD. a The progression of complex diseases is modeled as three states, including two stable states, i.e., a normal and a disease state with high stability and resilience, and an unstable pre-disease state with low stability and resilience [5, 9]. As the limit of the normal state, the pre-disease state is a critical state just before the onset of deterioration. b Given a number of reference samples that are generally from normal cohort and represent the healthy or relatively healthy individuals, the sKLD score is capable to quantitatively evaluate the difference between two distributions of each gene, i.e., the background distribution that generated from a set of reference samples, and a perturbed distribution yielded from the single case sample. The detailed procedure and description of deriving the two distributions are presented in Methods section. c During the progression of a complex disease, the pre-disease state is indicated by the significant change of sKLD, i.e., the sKLD changes gradually when the system is in the normal state, while it increases abruptly when the system approaches the tipping point] The rapid development of high-throughput technology provides new insights for computational analysis, even when there is only one single sample available. Actually, based on a sample of high-throughput data, it is possible to measure the expressions of thousands of genes simultaneously. Such high-dimensional observation at the genome-wide scale not only provides the global view of a biological system, but also presents the accumulated effects of its long-term dynamics. Motivated by this point, in this study we develop a data-driven computational method and achieve the single-sample detection of the pre-disease state, by exploring the rich dynamical information from the high-throughput omics data. Specifically, it is found that the qualitative state change often causes the significant changes in the distributions of some genes’ expression. Therefore, a novel index, the single-sample Kullback–Leibler divergence (sKLD), is proposed to quantify the disturbance brought by the single case sample on the background distribution, where the background or reference samples refer to samples collected from a few healthy/relatively healthy individuals. Correspondingly, an applicable algorithm is developed based on sKLD (Fig. 1b), including a procedure of simulating the background distribution for each gene, evaluating the perturbation to the background distribution triggered by a single case sample, detecting the early-warning signal and identifying the pre-disease state. During this procedure, a group of biomolecules whose expressions are highly fluctuating before the critical transition are also picked out as the sKLD-signaling marker for further practical application. This new approach has been applied to a numerical simulation, and six real datasets including lung squamous cell carcinoma (LUSC), lung adenocarcinoma (LUAD), stomach adenocarcinoma (STAD), thyroid carcinoma (THCA), colon adenocarcinoma (COAD) from the cancer genome atlas (TCGA) database and acute lung injury (GSE2565) from the NCBI GEO database. The identified pre-disease states all agree with the experimental observation or survival analysis. And the corresponding signaling markers have been validated by functional enrichment. RESULTS We present the definition and algorithm of sKLD score in Methods section. Here, we used